Globus Medical

spine nerves
MedTech

Globus Medical to buy neurostim developer Nevro for $250M

With Globus paying $5.85 for each of Nevro’s outstanding shares, that amounts to a 27% premium over a 90-day weighted average.
Conor Hale Feb 10, 2025 10:51am
MA

NuVasive, Globus Medical ink $3.1B merger

Feb 10, 2023 10:45am
A black man and a white man shaking hands

Globus plans to boost sales with Alphatec acquisition

Jul 27, 2016 3:54pm